title: Regulation of clusterin expression in mammary epithelial cells.
abstract: Mammary epithelial cells undergo changes in growth, invasion, differentiation, and dedifferentiation throughout much of adult hood, and most strikingly during pregnancy, lactation, and involution. Clusterin is a multifunctional glycoprotein that is involved in the differentiation and morphogenesis of epithelia, and that is important in the regulation of postnatal mammary gland development. However, the mechanisms that regulate clusterin expression are still poorly understood. Here, we show that clusterin is up-regulated twice during mouse mammary gland development, a first time at the end of pregnancy and a second time at the beginning of the involution. These points of clusterin up-regulation coincide with the dramatic phenotypic and functional changes occurring in the mammary gland. Using cell culture conditions that resemble the regulatory microenvironment in vivo, we determined that the factors responsible for the first up-regulation of clusterin levels can include the extracellular matrix component, laminin, and the lactogenic hormones, prolactin and hydrocortisone. On the other hand, the second and most dramatic up-regulation of clusterin can be due to the potent induction by TGF-beta1, and this up-regulation by TGF-beta1 is dependent on beta1 integrin ligand-binding activity. Moreover, the level of expression of beta-casein, a marker of mammary epithelial cell differentiation, was decreased upon treatment of cells with clusterin siRNA. Overall, these findings reveal several novel pathways for the regulation of clusterin expression during mammary gland development, and suggest that clusterin is a morphogenic factor that plays a key role during differentiation.
authors.affiliation: California Pacific Medical Center, Cancer Research Institute, 475 Brannan Street, Suite 220, San Francisco, CA 94107, USA.
authors.forename: Yoko
authors.initials: Y
authors.lastname: Itahana
authors.forename: Marie
authors.initials: M
authors.lastname: Piens
authors.forename: Tomoki
authors.initials: T
authors.lastname: Sumida
authors.forename: Sylvia
authors.initials: S
authors.lastname: Fong
authors.forename: John
authors.initials: J
authors.lastname: Muschler
authors.forename: Pierre-Yves
authors.initials: PY
authors.lastname: Desprez
mesh_terms: D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002454:Cell Differentiation; D002460:Cell Line; D051152:Clusterin / Q000378:metabolism*; D018076:DNA, Complementary / Q000235:genetics; D004347:Drug Interactions; D004847:Epithelial Cells / Q000187:drug effects / Q000378:metabolism*; D005109:Extracellular Matrix / Q000502:physiology; D005260:Female; D018507:Gene Expression Regulation, Developmental; D006728:Hormones / Q000494:pharmacology; D039641:Integrin beta Chains / Q000502:physiology; D008321:Mammary Glands, Animal / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D051379:Mice; D008807:Mice, Inbred BALB C; D009693:Nucleic Acid Hybridization / Q000379:methods; D015398:Signal Transduction; D014162:Transfection; D053773:Transforming Growth Factor beta1 / Q000494:pharmacology
chemical_list: D000906:Antibodies; D051152:Clusterin; D018076:DNA, Complementary; D006728:Hormones; D039641:Integrin beta Chains; D053773:Transforming Growth Factor beta1